Skip to main content
Zeid Kayali, MD, Gastroenterology, Rialto, CA

ZeidKKayaliMD

Gastroenterology Rialto, CA

Hepatology & Liver Transplantation

Associate Professor, Medicine, Loma Linda University School of Medicine

Are you Dr. Kayali?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 45 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    2006 N Riverside Ave
    Ste A
    Rialto, CA 92377
    Phone+1 909-883-2999
    Fax+1 909-883-2997

Summary

  • Dr. Zeid Kayali, MD is a gastroenterologist in Rialto, California. He is currently licensed to practice medicine in California, Nevada, and Iowa. He is affiliated with Arrowhead Regional Medical Center and is an Associate Professor at Loma Linda University School of Medicine.

Education & Training

  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Gastroenterology, 2002 - 2004
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsFellowship, Gastroenterology, 2001 - 2002
  • Catholic Health Partners Services
    Catholic Health Partners ServicesResidency, Internal Medicine, 1997 - 2000
  • University of Aleppo Faculty of Medicine
    University of Aleppo Faculty of MedicineClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2000 - 2026
  • NV State Medical License
    NV State Medical License 2006 - 2025
  • IA State Medical License
    IA State Medical License 2001 - 2003
  • IL State Medical License
    IL State Medical License 1997 - 2002
  • American Board of Internal Medicine Gastroenterology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Kintor Hits Back at Press Criticism of COVID Drug with US Trial Update
    Kintor Hits Back at Press Criticism of COVID Drug with US Trial UpdateMay 19th, 2021
  • NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of NASH
    NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of NASHAugust 4th, 2023